Patents Assigned to EVORX TECHNOLOGIES, INC.
  • BETA-CATENIN BARCODED PEPTIDES
    Publication number: 20190284249
    Abstract: Disclosed are peptide-mRNA fusion products, oligonucleotide structures, methods of producing and using the same.
    Type: Application
    Filed: April 24, 2017
    Publication date: September 19, 2019
    Applicant: EVORX TECHNOLOGIES, INC.
    Inventors: STEPHEN VINCENT FIACCO, AMANDA NICOLE HARDY, TERRY TORAO TAKAHASHI
  • Methods and compositions for controlling gene expression and treating cancer
    Patent number: 10323067
    Abstract: Disclosed are peptides which specifically bind to preselected pre-miRNA or pri-miRNA targets, methods of down-regulating EMT in a cell using such peptides, and methods of preparing such peptides. Also provided are therapeutic compositions comprising peptides that specifically bind a preselected cancer marker which is a peptide or which is a pre-miRNA or a pri-miRNA and methods of treatment using the same.
    Type: Grant
    Filed: May 14, 2015
    Date of Patent: June 18, 2019
    Assignee: EVORX TECHNOLOGIES, INC.
    Inventors: Stephen V. Fiacco, Amanda N. Hardy, Terry T. Takahashi
  • HER-2-SPECIFIC CYCLIZED SUPR PEPTIDES
    Publication number: 20180327453
    Abstract: Disclosed are highly potent peptides, peptide conjugates, host cells and compositions containing one or more of these peptides, peptide conjugates and/or host cells that are useful to inhibit the growth of a breast cancer cell or treat breast cancer in a patient in need of such treatment.
    Type: Application
    Filed: November 7, 2016
    Publication date: November 15, 2018
    Applicant: EVORX TECHNOLOGIES, INC.
    Inventors: Stephen FIACCO, Amanda HARDY